The pharmaceutical sector continues to evolve as health systems worldwide adapt to new clinical expectations, regulatory pathways, and patient needs. Within this environment, interest in diflunisal—a decades-old nonsteroidal anti-inflammatory drug—has resurged as researchers investigate broader therapeutic applications, especially in fields where inflammation and chronic pain...
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek